Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2003
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191090 Anemia therapy; hydrogenation dextrin; reacting with ferric salt; complexing
10/09/2003US20030191089 Anticancer agents
10/09/2003US20030191080 Cardiovascular disorders; hypotensive agents
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191055 Inhibiting development of microvessels withins coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy
10/09/2003US20030191051 Combination therapy for the treatment of bacterial infections
10/09/2003US20030191048 Gene expression profile for KSHV infection and methods for treating same
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis
10/09/2003US20030190693 Identifying inhibitors and activators of eukaryotic potassium channels
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190686 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmacetical compositions containing such compounds
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190659 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190607 Polymorphisms in human pyruvate dehydrogenase E1 beta (PDH E1 beta) gene; for analysing allelic variation; bioinformatic applications
10/09/2003US20030190597 For drug screening and development, exposing to a compound that paralyzes or kills nematoda
10/09/2003US20030190381 Medical composition for balancing bodily processes
10/09/2003US20030190373 Sodium bicarbonate/sodium chloride micronized slurry
10/09/2003US20030190372 Cough depressant composition containing iron for angiotensin-converting enzyme inhibitor inducing cough
10/09/2003US20030190369 Vitamin formulation for enhancing bone strength
10/09/2003US20030190357 Compositions for delivery of a cortisol antagonist
10/09/2003US20030190340 Gel formulations of 1-hydroxy-2(H)pyridone derivatives, which contain solvents and hydrophilic gel-forming agents
10/09/2003US20030190308 DNA vaccines (gag proteins, nef proteins) for prophylaxis and treatment of HIV infections; drug delivery
10/09/2003US20030190303 For treating allergic disorders characterized by a local immune response including inflammatory skin reactions, asthma, and arthritis
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2481795A1 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
10/09/2003CA2481236A1 Volume efficient controlled release dosage form
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480634A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003CA2480632A1 Drug delivery particle
10/09/2003CA2480630A1 Tissue treatment
10/09/2003CA2480372A1 Combination therapy using trefoil peptides
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2480141A1 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003CA2480138A1 Transcellular drug delivery system
10/09/2003CA2480048A1 Chemiluminescent treatment of acne
10/09/2003CA2479995A1 Dispensing apparatus and cartridge
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479807A1 Antimicrobial polymer conjugates
10/09/2003CA2479750A1 Fibrinogen binding moieties
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478470A1 Solubilization of weak bases
10/09/2003CA2478017A1 Therapeutic agent for glomerular disease
10/09/2003CA2474512A1 Method for producing pseudo islets
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350522A1 Topical anesthesia compositions
10/08/2003EP1350515A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
10/08/2003EP1350511A1 Medicinal compositions containing aspirin
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1350111A2 Detection of allergen-specific ige
10/08/2003EP1350104A2 Presenilin enhancers
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349861A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
10/08/2003EP1349857A1 Purine derivatives as purinergic receptor antagonists
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349846A1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349576A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological di
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349568A1 Immunomodulatory constructs and their uses
10/08/2003EP1349563A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders
10/08/2003EP1349556A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
10/08/2003EP1349555A1 Treatment of cancer by reduction of intracellular energy and pyrimidines
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
10/08/2003EP1349548A2 Methods and compositions for treating periodontal disease
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1349541A1 Self emulsifying lipid matrix (selm)
10/08/2003EP1349531A1 Spaced drug delivery system
10/08/2003EP1349457A1 Liquid antimicrobial compositions
10/08/2003EP1272230B1 Injectable bone mineral substitute material comprising bone cement and oil
10/08/2003EP1227808B1 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
10/08/2003EP1140018B1 Polyol/oil suspensions for the sustained release of proteins
10/08/2003EP1100530B1 In-vitro stimulation of beta cell proliferation
10/08/2003EP1073455B1 Compositions and methods for extending the action of clostridial neurotoxin
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0863740B1 Reduction of hair growth
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003CN1447919A Use of antibodies against specific MHC-Peptide complexes
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
1 ... 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 ... 1151